155 related articles for article (PubMed ID: 23581491)
1. New multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine derivatives with antioxidant, antihyperlipidemic, and antidiabetic action.
Ladopoulou E; Matralis AN; Kourounakis AP
J Med Chem; 2013 Apr; 56(8):3330-8. PubMed ID: 23581491
[TBL] [Abstract][Full Text] [Related]
2. Novel benzoxazine and benzothiazine derivatives as multifunctional antihyperlipidemic agents.
Matralis AN; Katselou MG; Nikitakis A; Kourounakis AP
J Med Chem; 2011 Aug; 54(15):5583-91. PubMed ID: 21702499
[TBL] [Abstract][Full Text] [Related]
3. Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
Matralis AN; Kourounakis AP
J Med Chem; 2014 Mar; 57(6):2568-81. PubMed ID: 24568631
[TBL] [Abstract][Full Text] [Related]
4. A new multifunctional hydroxytyrosol-fenofibrate with antidiabetic, antihyperlipidemic, antioxidant and antiinflammatory action.
Xie Y; Xu Y; Chen Z; Lu W; Li N; Wang Q; Shao L; Li Y; Yang G; Bian X
Biomed Pharmacother; 2017 Nov; 95():1749-1758. PubMed ID: 28962080
[TBL] [Abstract][Full Text] [Related]
5. Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity.
Katselou MG; Matralis AN; Kourounakis AP
Eur J Med Chem; 2017 Sep; 138():748-760. PubMed ID: 28728107
[TBL] [Abstract][Full Text] [Related]
6. Design of more potent squalene synthase inhibitors with multiple activities.
Kourounakis AP; Matralis AN; Nikitakis A
Bioorg Med Chem; 2010 Nov; 18(21):7402-12. PubMed ID: 20888243
[TBL] [Abstract][Full Text] [Related]
7. Hydroxytyrosol nicotinate, a new multifunctional hypolipidemic and hypoglycemic agent.
Xie YD; Chen ZZ; Li N; Lu WF; Xu YH; Lin YY; Shao LH; Wang QT; Guo LY; Gao YQ; Yang GD; Li YP; Bian XL
Biomed Pharmacother; 2018 Mar; 99():715-724. PubMed ID: 29710469
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.
Pandeti S; Sonkar R; Shukla A; Bhatia G; Tadigoppula N
Eur J Med Chem; 2013 Nov; 69():439-48. PubMed ID: 24090915
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic, antihyperlipidemic and antioxidant activities of methanolic extract of Amaranthus viridis Linn in alloxan induced diabetic rats.
Ashok Kumar BS; Lakshman K; Jayaveea KN; Sheshadri Shekar D; Saleemulla Khan ; Thippeswamy BS; Veerapur VP
Exp Toxicol Pathol; 2012 Jan; 64(1-2):75-9. PubMed ID: 20643534
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel N-(2-hydroxy-2-p-tolylethyl)-amide and N-(2-oxo-2-p-tolylethyl)-amide derivatives and their antidyslipidemic and antioxidant activity.
Narender T; Rajendar K; Sarkar S; Singh VK; Chaturvedi U; Khanna AK; Bhatia G
Bioorg Med Chem Lett; 2011 Nov; 21(21):6393-7. PubMed ID: 21930379
[TBL] [Abstract][Full Text] [Related]
11. Flavone-based novel antidiabetic and antidyslipidemic agents.
Verma AK; Singh H; Satyanarayana M; Srivastava SP; Tiwari P; Singh AB; Dwivedi AK; Singh SK; Srivastava M; Nath C; Raghubir R; Srivastava AK; Pratap R
J Med Chem; 2012 May; 55(10):4551-67. PubMed ID: 22524508
[TBL] [Abstract][Full Text] [Related]
12. Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.
Kourounakis AP; Charitos C; Rekka EA; Kourounakis PN
J Med Chem; 2008 Sep; 51(18):5861-5. PubMed ID: 18754614
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analogues.
Stocker R
Curr Opin Lipidol; 2009 Jun; 20(3):227-35. PubMed ID: 19373083
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new N-acryl-1-amino-2-phenylethanol and N-acyl-1-amino-3-aryloxypropanols and evaluation of their antihyperlipidemic, LDL-oxidation and antioxidant activity.
Sarkar S; Sonkar R; Bhatia G; Tadigoppula N
Eur J Med Chem; 2014 Jun; 80():135-44. PubMed ID: 24769351
[TBL] [Abstract][Full Text] [Related]
15. Antihyperglycemic and antihyperlipidemic effects of newly synthesized glibenclamide analogues on streptozotocin-diabetic rats.
Ahmadi A; Khalili M; Farsadrooh M; Ghiasi M; Nahri-Niknafs B
Drug Res (Stuttg); 2013 Dec; 63(12):614-9. PubMed ID: 23828271
[TBL] [Abstract][Full Text] [Related]
16. Antihyperglycemic, antihyperlipidemic and antioxidant activities of polysaccharides from Catathelasma ventricosum in streptozotocin-induced diabetic mice.
Liu Y; Sun J; Rao S; Su Y; Yang Y
Food Chem Toxicol; 2013 Jul; 57():39-45. PubMed ID: 23500773
[TBL] [Abstract][Full Text] [Related]
17. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
Tooulia KK; Theodosis-Nobelos P; Rekka EA
Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
Sashidhara KV; Dodda RP; Sonkar R; Palnati GR; Bhatia G
Eur J Med Chem; 2014 Jun; 81():499-509. PubMed ID: 24871900
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice.
Kumar A; Sharma S; Gupta LP; Ahmad P; Srivastava SP; Rahuja N; Tamrakar AK; Srivastava AK
Bioorg Med Chem; 2012 Mar; 20(6):2172-9. PubMed ID: 22341243
[TBL] [Abstract][Full Text] [Related]
20. Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif.
Reddy KA; Lohray BB; Bhushan V; Reddy AS; Kishore PH; Rao VV; Saibaba V; Bajji AC; Rajesh BM; Reddy KV; Chakrabarti R; Rajagopalan R
Bioorg Med Chem Lett; 1998 May; 8(9):999-1002. PubMed ID: 9871696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
